Search

Your search keyword '"Bemelman, Frederike J."' showing total 567 results

Search Constraints

Start Over You searched for: Author "Bemelman, Frederike J." Remove constraint Author: "Bemelman, Frederike J."
567 results on '"Bemelman, Frederike J."'

Search Results

1. Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients

2. Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation—A Retrospective Multicenter Outcome Analysis

4. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

5. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study

6. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells

7. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

8. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

9. Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses

11. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis

14. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

15. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

18. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

19. Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study

20. The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment

23. Donor characteristics and their impact on kidney transplantation outcomes: Results from two nationwide instrumental variable analyses based on outcomes of donor kidney pairs accepted for transplantation

24. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

25. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

26. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

27. Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study

28. Alkaline phosphatase treatment of acute kidney injury—an update.

29. Infiltrative classical monocyte-derived andSPP1lipid-associated macrophages mediate inflammation and fibrosis in ANCA-associated glomerulonephritis

30. The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients

32. Cardiovascular risk in ANCA-associated vasculitis: monocyte phenotyping reveals distinctive signatures between serological subsets

33. Determination of the clinical relevance of donor epitope‐specific HLA‐antibodies in kidney transplantation

34. SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

37. A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss

38. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

39. Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation—A Retrospective Multicenter Outcome Analysis

40. Antibodies against ARHGDIB are associated with long-term kidney graft loss

41. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

42. Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation

43. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.

44. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

45. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

46. Association of obesity with 3-month mortality in kidney failure patients with COVID-19

47. Intercontinental Deceased-donor Kidney Transplantation in Dutch Antilleans: Favorable Outcomes Despite Prolonged Ischemia

49. Alkaline phosphatase to treat ischaemia–reperfusion injury in living‐donor kidney transplantation: APhIRI I feasibility pilot study.

Catalog

Books, media, physical & digital resources